Castleview Partners’s VanEck CLO ETF CLOI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$958K Buy
18,171
+3,306
+22% +$174K 0.49% 45
2025
Q4
$785K Sell
14,865
-1,804
-11% -$95.5K 0.39% 59
2025
Q3
$885K Sell
16,669
-22,172
-57% -$1.17M 0.48% 42
2025
Q2
$2.06M Sell
38,841
-4,928
-11% -$259K 1.32% 16
2025
Q1
$2.31M Buy
43,769
+5,936
+16% +$314K 1.57% 9
2024
Q4
$2M Sell
37,833
-11,214
-23% -$594K 1.08% 15
2024
Q3
$2.6M Buy
49,047
+7,374
+18% +$390K 1.5% 10
2024
Q2
$2.21M Buy
41,673
+4,382
+12% +$231K 1.25% 11
2024
Q1
$1.97M Buy
37,291
+31,083
+501% +$1.63M 1.1% 13
2023
Q4
$324K Buy
+6,208
New +$324K 0.23% 103

Other funds holding CLOI

Castleview Partners's CLOI Position: Q1 2026 in Review

Castleview Partners increased its VanEck CLO ETF (CLOI) stake by 22% in Q1 2026, buying an estimated $174K and bringing the position to 18,171 shares worth $958K. The position accounts for 0.49% of the portfolio, ranked #45.

Castleview Partners first reported a position in CLOI in Q4 2023 and has held it in 10 quarters since. The position peaked at $2.6M in Q3 2024. 167 funds tracked by Wall St. Rank hold CLOI as of Q1 2026.

  • Castleview Partners held 18,171 shares of VanEck CLO ETF worth $958K as of Q1 2026.
  • Castleview Partners bought 3,306 VanEck CLO ETF shares in Q1 2026, an estimated $174K.
  • VanEck CLO ETF made up 0.49% of Castleview Partners's portfolio in Q1 2026, its #45 holding.
  • Castleview Partners first reported a position in VanEck CLO ETF in Q4 2023 and has held it in 10 quarters since.
  • Castleview Partners's VanEck CLO ETF position peaked at $2.6M in Q3 2024.
  • 167 funds tracked by Wall St. Rank held VanEck CLO ETF as of Q1 2026.

Based on Castleview Partners's 13F filing for Q1 2026, filed 1 May 2026.